Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dandara Baia Bonifácio has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute and Chronic Effects of Green Tea Kombucha With and Without Grape Skin Extract on Immune and Oxidative Stress Markers in Beginner Runners: A Randomized Controlled Trial

    by Dandara Baia Bonifácio, Rayanne Santos de Paulo, Pedro Henrique Viana Mendes, Udielle Vermelho Lacerda, Rodrigo Rezende Cardoso, Helton de Sá Souza, Frederico Augusto Ribeiro de Barros, Josefina Bressan

    Green tea kombucha is an antioxidant‐rich beverage with promising health benefits. However, evidence regarding its effects in physically active individuals remains limited. This study investigated the acute and chronic effects of green tea kombucha, with or without grape skin extract, on immune and oxidative stress markers in beginner runners. This 12‐week randomized clinical trial included 90 healthy adults (18–45 years) allocated to three groups: control (CT‐G), green tea kombucha (GT‐G), and green tea kombucha with grape skin extract (GTG‐G). Participants performed supervised running training three times weekly following a polarized periodization model. Kombucha intake was not associated with significant changes in the primary outcome, ferric reducing antioxidant power (FRAP), nor in acute immune or oxidative responses to exercise ( p > 0.05). However, during the chronic period, the GT‐G showed increased neutrophils ( p = 0.026) and reduced lymphocytes ( p = 0.023) compared to the other groups. Fasting catalase (CAT) activity differed between groups GT‐G and CT‐G ( p = 0.037), despite no significant group x time interaction ( p = 0.157). A group × time interaction was detected for post‐exercise malondialdehyde concentrations ( p = 0.033), with no significant interaction in the post hoc test. Sensitivity analyses including all randomized participants confirmed the primary observations; however, false discovery rate (FDR) adjustments indicated these findings are exploratory. No additional effects were detected in GTG‐G. In conclusion, 12 weeks of green tea kombucha intake was associated with nominally significant changes in immune and oxidative markers during chronic running training, and further studies are needed to clarify these findings.

  • Open Access

    Acute and chronic effects of mixed nuts on energy metabolism in women at cardiometabolic risk: a randomized clinical trial

    by Dandara B. Bonifácio, Alessandra da Silva, Yuliana M.F. Estrada, Ana Paula S. Caldas, Helen H.M. Hermsdorff, Josefina Bressan

  • Open Access

    Effect of Green Tea Kombucha Within an Energy‐Restricted Diet on Cardiometabolic Risk Markers in Individuals With Excess Body Weight: A Randomized Controlled Trial

    by Dandara Baia Bonifácio, Gabriela Macedo Fraiz, Udielle Vermelho Lacerda, Rodrigo Rezende Cardoso, Thayná de Souza Coura Dias, Viviana Corich, Alessio Giacomini, Frederico Augusto Ribeiro de Barros, Josefina Bressan

    Green tea kombucha is a fermented beverage notable for its rich content of bioactive compounds, yet it remains underexplored. Thus, this study aimed to evaluate the effect of green tea kombucha consumption, in combination with an energy‐restricted diet, on traditional cardiometabolic risk markers in individuals with excess weight. This is a randomized controlled clinical trial in which 59 individuals with excess body weight (BMI >27 kg/m 2 ) were distributed into two parallel experimental groups: the control group, which followed an energy‐restricted diet (−500 kcal/day), and the kombucha group, which followed the same energy‐restricted diet + daily consumption of green tea kombucha (200 mL/day) for 10 weeks. At the end of the study, participants in the kombucha group showed a significant reduction in total cholesterol ( p = 0.024), LDL‐c ( p = 0.035), VLDL‐c ( p = 0.011), triglycerides ( p = 0.012), Castelli index II ( p = 0.002), and uric acid ( p = 0.027) compared to baseline. Both groups (control and kombucha) significantly reduced Castelli index I ( p = 0.015 and p = 0.007, respectively) and HOMA‐β ( p = 0.019 and p < 0.001, respectively) after the intervention. Only the control group showed a significant increase in glycated hemoglobin (within reference values) compared to pre‐intervention ( p = 0.004). Furthermore, men in the kombucha group showed a significant reduction in glycated hemoglobin compared to men in the control group ( p = 0.010). However, in the total sample ( Δ = final − initial), no significant differences were found between the control and kombucha groups ( p > 0.05) for any evaluated marker. In conclusion, the consumption of green tea kombucha, when combined with an energy‐restricted diet, shows promising cardiometabolic benefits in individuals with excess body weight.


  • Open Access

    Sex-specific differences in salivary microbiota composition and their associations with metabolic health in adults with excess body weight: a secondary cross-sectional analysis

    by Jhenifer Pereira da Costa, Gabriela Macedo Fraiz, Dandara Baia Bonifácio, Fermín I. Milagro, Josefina Bressan

    Objectives: Growing evidence links the oral microbiome to obesity-related outcomes, yet the influence of sex-related biological differences on salivary microbial profiles remains insufficiently explored. This exploratory study aimed to characterize the composition, abundance, and diversity of the salivary microbiota in Brazilian men and women with excess body weight and to examine its associations with cardiometabolic markers. Materials and methods: This cross-sectional secondary analysis of a randomized controlled trial (REBEC: RBR-9832wsx) included 59 adults with excess body weight. Salivary microbiota was profiled through amplification of the 16 S rRNA V4 region, and bioinformatics analyses were performed using the Microbiome Analyst (v2.0). Associations between microbial taxa and clinical variables were assessed using Spearman’s correlation. Results: Men exhibited greater alpha diversity at the family level by higher Shannon ( p = 0.015, r rb = 0.4) and Simpson ( p = 0.003, r rb = 0.5) indices. Sex-specific microbial differences were identified: men showed higher levels of genera Tannerella , Lachnoanaerobaculum , and Actinomyces , as well as the putative species-level taxons Tannerella serpentiformis and Lachnoanaerobaculum umeaense , whereas women demonstrated greater abundance of genera Campylobacter , Granulicatella , Moryella , and Scardovia . Among women, Granulicatella genera was positively associated with triglycerides and the TyG index. Conclusion: Men and women with excess body weight exhibited distinct salivary microbiota profiles, with differences in both diversity and taxonomic composition. Clinical relevance: Sex-specific differences in salivary microbiota composition may be associated with variations in metabolic markers. These findings are exploratory and hypothesis-generating, providing insight into sex-related patterns in the oral microbiome and may help inform future research exploring personalized approaches to cardiometabolic risk assessment.

  • Open Access

    Effect of regular green tea (Camellia sinensis) kombucha consumption on oxidative stress and endothelial health in individuals with excess body weight: a randomized controlled trial

    by Dandara Baia Bonifácio, Gabriela Macedo Fraiz, Udielle Vermelho Lacerda, Rodrigo Rezende Cardoso, Ana Claudia Pelissari Kravchychyn, Viviana Corich, Alessio Giacomini, Frederico Augusto Ribeiro de Barros, Josefina Bressan

    Kombucha is a fermented beverage rich in bioactive compounds. This beverage has demonstrated high antioxidant capacity in vitro and experimental animal studies. In this sense, this study aimed to evaluate the effect of daily consumption of green tea kombucha on oxidative stress and endothelial health in individuals with excess body weight. This is a randomized controlled clinical trial, lasting 10 weeks, during which the control group followed a healthy −500 kcal/d energy-restricted diet. In contrast, the kombucha group, in addition to the energy-restricted diet, consumed 200 ml of kombucha green tea daily. This study included men and women aged 18–45 years without chronic diseases. At the beginning and end of the study, fasting blood was collected, and colorimetric assays and immunoassay protocols evaluated markers of oxidative stress and endothelial health. Compared to the control group, kombucha consumption significantly reduced hydrogen peroxide (H2O2) levels (P = 0·007). Initial and final values were as follows: Control group (16·5 v. 15·09 µmol/ml; n 29) and Kombucha group (18·14 v. 14·67 µmol/ml; n 30). The other markers that were evaluated did not change after the kombucha consumption. In conclusion, daily consumption of 200 ml of green tea kombucha for 10 weeks reduces one pro-oxidant marker, without altering other markers of oxidative stress and endothelial health in individuals with excess body weight. Reducing a pro-oxidant marker suggests that kombucha is an antioxidant beverage with promising implications for human health. However, further studies are needed to elucidate other possible beneficial effects on health.


  • Open Access

    Benefits of Kombucha Consumption: A Systematic Review of Clinical Trials Focused on Microbiota and Metabolic Health

    by Gabriela Macedo Fraiz, Dandara Baia Bonifácio, Rayanne Santos de Paulo, Carolynne Martins Teixeira, Hércia Stampini Duarte Martino, Frederico Augusto Ribeiro de Barros, Fermín I. Milagro, Josefina Bressan

    Background: Fermented foods rich in bioactive compounds have been proposed as potential strategy to combat non-communicable diseases. Among them is kombucha, a beverage fermented from sugared Camellia sinensis tea by a symbiotic culture of bacteria and yeasts (SCOBY). Recently, there has been an increased focus on assessing the actual effect of this beverage on human health. In this manner, this systematic review aimed to gather clinical evidence on the impact of kombucha consumption on human health. Methods: The databases Cochrane CENTRAL, MEDLINE/PubMed, and Embase® were searched, and the risk of bias tool used was the Critical Appraisal Tools outlined in the Joanna Briggs Institute. This review followed the PRISMA guidelines and was registered on PROSPERO (CRD42024599464). Results: Eight clinical trials were included (two pre- and post-interventions and six randomized controlled trials) with durations ranging from 10 days to 10 weeks. Two studies reported beneficial effects of kombucha on gastrointestinal symptoms, such as reduced intensity of constipation-related complaints. Two trials observed changes in gut microbiota composition, including increased abundance in Bacteroidota, Akkermansiaceae, Saccharomyces, and Weizmannia coagulans, alongside reductions in Ruminococcus, Dorea, and Rhodotorula. Moreover, five clinical trials evaluated glucose metabolism, evidencing inconsistent results, and other studies identified improvements in salivary microbiota composition and serum metabolomic profile. Conclusion: These findings suggest that kombucha consumption may provide health benefits, particularly in alleviating gastrointestinal symptoms, and demonstrates a modest capacity for modulating gut and salivary microbiota, as well as metabolomic profiles. Although the results are promising, the heterogeneity of the studies and the limited number of available clinical trials highlight the need for further robust research to confirm these effects.


  • Open Access

    The Impact of Green Tea Kombucha on the Intestinal Health, Gut Microbiota, and Serum Metabolome of Individuals with Excess Body Weight in a Weight Loss Intervention: A Randomized Controlled Trial

    by Gabriela Macedo Fraiz, Dandara Baia Bonifácio, Udielle Vermelho Lacerda, Rodrigo Rezende Cardoso, Viviana Corich, Alessio Giacomini, Hércia Stampini Duarte Martino, Sergio Esteban-Echeverría, Ana Romo-Hualde, David Muñoz-Prieto, et al.

    Green tea kombucha (GTK) has emerged as a promising probiotic fermented beverage. Few studies have investigated its effect on human health, mainly focusing on intestinal health, microbiota composition, and metabolomics. The present study is a pioneer in investigating the effect of GTK consumption in individuals with excess body weight. This is a randomized controlled trial, lasting ten weeks, with two groups placed under an energy-restricted diet: control (CG, n = 29), kombucha (KG, n = 30; 200 mL/d). Biological samples and questionnaires were collected before and after the intervention. Microbiota analysis used an amplification of the V4 region of 16S rRNA. Serum untargeted metabolomics used HPLC-TOF mass spectrometry. Intestinal permeability considered the urine excretion of lactulose and mannitol, plasma zonulin, and LPS-binding protein. After the intervention, no differences related to intestinal permeability and microbiota were found between groups, but only the CG had increased fecal pH, lactulose/mannitol ratio, and zonulin. In addition to this, the KG reported lower gastrointestinal symptoms related to motility compared to the CG, and discriminant metabolites (e.g., diethyl malonate) were found strictly in the KG. GTK did not significantly improve gut microbiota and intestinal permeability. However, GTK ameliorated gastrointestinal symptoms and positively influenced the serum metabolome, which may contribute to enhancing the metabolic health of individuals with excess body weight.


  • Open Access

    Green Tea Kombucha Impacts Inflammation and Salivary Microbiota in Individuals with Excess Body Weight: A Randomized Controlled Trial

    by Gabriela Macedo Fraiz, Dandara Baia Bonifácio, Udielle Vermelho Lacerda, Rodrigo Rezende Cardoso, Viviana Corich, Alessio Giacomini, Hércia Stampini Duarte Martino, Sergio Esteban Echeverría, Frederico Augusto Ribeiro de Barros, Fermín I. Milagro, et al.

    Background: Green tea kombucha (GTK) is a fermented beverage with promising health benefits, but few studies proved its impact on human health. Thus, we aimed to investigate the impact of GTK on weight loss, inflammation, and salivary microbiota in individuals with excess body weight. Methods: This is a randomized controlled clinical trial that lasted 10 weeks with two groups of individuals with excess body weight: control (CG; n = 29; caloric restriction) and kombucha (KG; n = 30; caloric restriction + 200 mL GTK). Body composition, anthropometry, saliva, and blood collection were performed in the beginning and end of the intervention. Plasma interleukins were determined by flow cytometry. Salivary microbiota was analyzed by 16S rRNA sequencing. Results: Both groups decreased weight, BMI, and body fat (p < 0.001) after the intervention, but there were no differences between groups. The KG reduced lipid accumulation product (LAP) (p = 0.029). Both groups decreased IL-1β and IL-8, but IL-6 increased in the CG (p = 0.023) compared to the kombucha group. Alpha and beta diversity of salivary microbiota increased in the KG. Moreover, the KG presented lower Bacillota/Bacteroidota ratio (p = 0.028), and BMI was positively associated with the Bacillota phylum. Conclusions: GTK did not enhance weight loss, but it decreased the LAP. GTK helped in the inflammatory profile and induced positive changes in oral microbiota composition.


  • Effects of Grape Juice Consumption in Practitioners of Physical Activity: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

    by Dandara Baia Bonifácio, Leonara Martins Viana, Alessandra da Silva, Danúbia Joanes Rosa Guerra, Caroline Woelffel Silva, Frederico Augusto Ribeiro de Barros, Josefina Bressan


  • Acute effect of a beverage containing Brazil and cashew nuts on oxidative stress, lipemia, and blood pressure of women with cardiometabolic risk (Brazilian Nuts Study): a randomized clinical trial

    by Dandara Baia Bonifácio, Ana Paula Silva Caldas, Mirian Aparecida de Campos Costa, Daniela Mayumi Usuda Prado Rocha, Helen Hermana Miranda Hermsdorff, Josefina Bressan

    Nuts are important sources of antioxidants that combat oxidative stress and improve lipid profile as well as vascular function. However, the intake of typical Brazilian nuts and its acute effect on cardiovascular health needs to be better understood. Thus, the present study aimed to evaluate the acute effect of a beverage containing cashew ( Anacardium occidentale L.) and Brazil nuts ( Bertholletia excelsa H.B.K.) on postprandial oxidative stress, lipemia, and blood pressure of adult women aged 20 to 55 years with cardiometabolic risk. This was an acute, randomized, parallel arm, controlled clinical trial. The participants received either a beverage containing nuts (30 g Brazil nuts + 15 g cashew nuts) or a beverage without nuts with similar macronutrient composition. Oxidative stress markers and lipid profiles were evaluated at fasting and 4 h after beverage consumption. Blood pressure was measured during fasting and after beverage intake (1, 2, 3, and 4 h). In the postprandial state, there was a greater reduction in malondialdehyde levels in the intervention group compared to the control group (−12.3 ± 0.59 vs. −10.7 ± 0.43 µmol/mL; p < 0.05), which was positively correlated with the concentrations of TG ( r = 0.399; p < 0.05), VLDL ( r = 0.399; p < 0.05), TG/HDL ( r = 0.380; p < 0.05), and blood pressure (iAUC SBP r = 0.391; p < 0.05, iAUC DBP r = 0.409; p < 0.05). The remaining oxidative stress markers showed similar postprandial changes between groups. In women with cardiometabolic risk, a beverage containing Brazilian nuts promoted a significant acute reduction on postprandial malondialdehyde levels. The study was registered in the Brazilian Clinical Trials Registry—ReBEC (protocol: RBR-3ntxrm).